Moberg Pharma AB (publ)
MOB
Rank in Stocks
#22782
Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to... Moberg Pharma AB (publ) functions as a pharmaceutical company, dedicated to both crafting and globally marketing medical solutions throughout Europe, the United States, and various international territories. A notable product within its development portfolio is MOB-015, a treatment designed for nail fungus, which has successfully concluded its Phase III clinical trials. Established in 2006, this enterprise is headquartered in Bromma, Sweden. It was previously known as Moberg Derma AB (publ) until its rebranding to the current name in May 2013.
Share Price
$1.05
Last synced: 2026-11-09
Market Cap
$49.77M
Change (1 day)
0.34%
Change (1 year)
-2.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Moberg Pharma AB (publ) (MOB)
Category
Healthcare
Operating Margin for Moberg Pharma AB (publ) (MOB)
Operating Margin as of November 2026 TTM: -134.49%
According to Moberg Pharma AB (publ)'s latest financial reports, its current operating margin (TTM) is -134.49%. At the end of 2025 the company had an operating margin of -206.80%.
Operating Margin history for Moberg Pharma AB (publ) from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -134.49% | -34.97% |
| 2025 | -206.80% | -93.75% |
| 2024 | -3,310.88% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | -9,911.59% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -64.42% | -536.45% |
| 2018 | 14.76% | 26.91% |
| 2017 | 11.63% | -37.47% |
| 2016 | 18.60% | 50.97% |
| 2015 | 12.32% | 43.09% |
| 2014 | 8.61% | -196.42% |
| 2013 | -8.93% | -179.73% |
| 2012 | 11.20% | -182.47% |
| 2011 | -13.58% | -96.16% |
| 2010 | -353.85% | -76.44% |
| 2009 | -1,501.91% | 0.00% |
| 2008 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.14% |
DE
|
|
| 19.68% | -100.15% |
DE
|
|
| 13.26% | -100.10% |
JP
|
|
| 17.08% | -100.13% |
CH
|
|
| 14.92% | -100.11% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Moberg Pharma AB (publ)'s operating margin
What is Moberg Pharma AB (publ)'s operating margin?
Moberg Pharma AB (publ)'s operating margin is -134.49%, as of Nov 2026.
What was Moberg Pharma AB (publ)'s operating margin in 2025?
In 2025, Moberg Pharma AB (publ)'s operating margin was -206.80%, compared with -3,310.88% in 2024.
How has Moberg Pharma AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Moberg Pharma AB (publ)'s operating margin was highest in 2023 (0.00%) and lowest in 2022 (-9,911.59%).
How does Moberg Pharma AB (publ)'s operating margin compare with similar companies?
Moberg Pharma AB (publ)'s operating margin (-134.49%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.